Systemic Bio Opens StateoftheArt Laboratory for Bioprinted OrganonaChip RD Production to Accelerate Drug Discovery Development 3D Sys NYSEDDD

HOUSTON, April 05, 2023 (GLOBE NEWSWIRE) — Today, Systemic Bio™, a 3D Systems DDD company, announced the opening of its new headquarters for hydrogel scaffold manufacturing and organ-on-a-chip R&D to facilitate its mission to accelerate drug discovery and development. This state-of-the-art facility contains a cleanroom for bioprinted hydrogel production and is located in the TMC Innovation Factory Labs on the Texas Medical Center Campus in Houston. From this location, Systemic Bio’s engineers and scientists will continue the development and production of the company’s proprietary h-VIOS™ (human vascularized integrated organ systems) organ-on-a-chip platform. h-VIOS is a versatile organ-on-a-chip platform that can…